Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL424728 | 0.83 | TSHR (0.73) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL16241997 | 0.75 | TSHR (0.55) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL807575 | 0.75 | TSHR (0.55) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL67741 | 0.75 | TSHR (0.55) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL1538330 | 0.73 | TSHR (0.61) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL26915 | 0.73 | KIF11 (0.70) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL3423876 | 0.73 | KIF11 (0.70) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL17923896 | 0.73 | TSHR (0.61) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL6524730 | 0.73 | TSHR (0.52) | TSHRLMNATYRKIF11ALDH1A1 | |
| SCHEMBL6516058 | 0.73 | TSHR (0.52) | TSHRLMNATYRKIF11ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621272-B | Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2024-03-29 | — | — | CN | claimed |
| CN-114621271-B | Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2024-03-29 | — | — | CN | claimed |
| CN-114621274-B | Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2024-03-22 | — | — | CN | claimed |
| CN-114621273-B | Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2024-03-22 | — | — | CN | claimed |
| CN-114621273-A | Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2022-06-14 | — | — | CN | claimed |
| CN-114621272-A | Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2022-06-14 | — | — | CN | claimed |
| CN-114621271-A | Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2022-06-14 | — | — | CN | claimed |
| CN-114621274-A | Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same | 季华实验室 | 2022-06-14 | — | — | CN | claimed |
| WO-2020237225-A1 | FUNCTIONALIZED GOLD CARBENE NAPHTHOQUINONE COMPLEXES FOR USE IN THE TREATMENT OF CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-11-26 | — | — | WO | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-6713146-B2 | SINGLY RECORDABLE COMPACT DISC (CD-R) | BAYER AKTIENGESELLSCHAFT (DE) | 2004-03-30 | — | — | US | claimed |
| US-6562840-B1 | Non-peptidic inhibitors of proteolytic enzymes such as urokinase | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | claimed |
| US-20020172793-A1 | Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer | LANXESS DEUTSCHLAND GMBH (DE) | 2002-11-21 | — | — | US | claimed |
| US-20020127366-A1 | Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light | LANXESS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | claimed |
| EP-1150979-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | ILLIG CARL R (US) | 2001-10-18 | — | — | US | claimed |
| US-6291514-B1 | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | claimed |
| WO-2000047578-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0635508-B1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | ASAHI CHEMICAL IND (JP) | 1999-10-06 | — | — | EP | claimed |
| EP-0635508-A1 | TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1995-01-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | SERPINE1, PRSS3, PRSS2 | TSHR 1131/4885LMNA 850/4885TYR 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.